The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.

IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.

EU Logoefpia Logo


IMI 2 Open Info Day - registration open

Registration for the IMI 2 Open Info Day on 30 September in Brussels is now open.

Sign up to learn more about the IMI 2 rules and procedures as well as the first Call topics.


  • A life-saving technology

    IMI project SUMMIT has developed an ultrasound device to identify patients at imminent risk of a heart attack or stroke

    ... more
  • Action on autism

    Watch a video on how EU-AIMS is developing tools to boost our understanding of autism, paving the way for new treatments

    ... more
  • Get on-course!

    With over 5 000 courses, on-course, run by the EMTRAIN project, is Europe's most comprehensive biomedical R&D postgrad course portal

    ... more
  • Innovation in action

    IMI's 46 projects have a combined budget of €1.6 billion and are tackling some of the toughest challenges in drug development.

    ... more
  • Patient power!

    EUPATI is developing educational resources that will empower patients to engage more effectively in the drug research and development process

    ... more
  • Schizophrenia breakthrough

    NEWMEDS project research published in Nature reveals that genetic variants linked with schizophrenia have an impact in healthy carriers

    ... more
All projects


IMI 2 - Call 1 gives universities, SMEs, patient organisations and others the chance to apply to take part in exciting new projects on:

  • type 1 diabetes
  • retinal diseases

Deadline: 12 November 2014


  • 28/08/2014 : RT @fastercures: Consortia-pedia isn't just fun to say, it's a great resource for navigating the #research-by-consortium model
  • 28/08/2014 : RT @eupatients: European Patients' academy: Where are we today?
  • 27/08/2014 : RT @eupatients: WANTED: New ways of teaching and learning for the future of patient-guided health education

Follow us on Twitter